Correction to: Bone Marrow Transplantation (2016) 52, 209–215; doi:10.1038/bmt.2016.266; published online 7 November 2016
Since the publication of this article, it has been noted that an acknowledgement was inadvertently not included in the paper. The acknowledgement is now given here:
AP acknowledges funding from The Haematology and Stem Cell Theme of the Oxford Biomedical Research Centre (BRC).
The authors would like to apologise for this error.
Additional information
The online version of the original article can be found at 10.1038/bmt.2016.266
Rights and permissions
About this article
Cite this article
Robin, M., Porcher, R., Zinke-Cerwenka, W. et al. Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant 52, 1081 (2017). https://doi.org/10.1038/bmt.2017.86
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.86
This article is cited by
-
Management of the Older Patient with Myelodysplastic Syndrome
Drugs & Aging (2021)
-
Myelodysplastic Syndromes: How to Recognize Risk and Avoid Acute Myeloid Leukemia Transformation
Current Oncology Reports (2020)
